2030 年までの北米バイオプロダクション市場予測 - 地域別分析 - 製品別 (生物製剤およびバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他)、用途別 (関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他)、機器別 (上流機器、下流機器、バイオリアクター、消耗品および付属品)、エンドユーザー別 (バイオ医薬品会社、契約製造組織、その他)
再生医療の採用増加が北米のバイオプロダクション市場を牽引
再生療法は、細胞、組織、臓器の再生を促進し、それらの機能を回復させます。毎年、再生医療のヒト臨床試験申請が多数、食品医薬品局（FDA）に提出されています。再生医療連合によると、2019年（第3四半期）には、再生医療を利用した臨床試験が世界中で1,052件実施されていました。 2019年には218件の細胞療法試験（第I相41件、第II相147件、第III相30件）が進行中でした。慢性疾患に対する効果的なソリューションを提供するために、再生医療は急速に進歩しています。細胞療法は、再生医療分野で最も急速に成長しているセグメントの1つです。ノバルティスのKymriahは、B細胞急性白血病の治療に提供された最初の細胞療法ソリューションでした。さらに、再生医療プロバイダーであるRepliCelは、パイプラインに幅広い再生医療製品を持っており、RCH-01、RCS-01、およびRCT-01の3つの製品が開発段階にあります。さらに、Sernovaは再生医療技術の開発に取り組んでおり、糖尿病、血友病A、甲状腺機能亢進症などの疾患に対する製品の膨大なパイプラインを持っています。このように、再生医療の採用の増加がバイオプロダクション市場を牽引しています。
北米バイオプロダクション市場の概要
北米バイオプロダクション市場は、米国、カナダ、メキシコに細分化されています。メキシコでは、幹細胞療法の医療ツーリズムの増加により、細胞療法の需要が非常に注目されています。北米のバイオプロダクション市場は、糖尿病や不妊症の発生率の増加、およびバイオシミラーの製品開発の増加により、2022年に最大の市場シェアを占めました。
遺伝性および細胞性疾患の発生率の増加により、細胞療法の需要が高まっています。細胞および遺伝子治療パイプラインに関する2020年のPhRMAレポートによると、米国ではがんから遺伝性疾患、神経疾患まで、さまざまな疾患や状態を対象とする400の細胞および遺伝子治療が開発中です。 2020年2月現在、米国ではがん、眼疾患、まれな遺伝性疾患の治療薬として、9つの細胞または遺伝子治療製品が承認されています。また、国内で細胞療法を革新するスタートアップ企業が増えています。
北米のバイオプロダクション市場の収益と2030年までの予測（百万米ドル）
北米のバイオプロダクション市場のセグメンテーション
北米のバイオプロダクション市場は、製品、アプリケーション、機器、エンドユーザー、および国に分類されています。
製品に基づいて、北米のバイオプロダクション市場は、生物製剤とバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他に分類されています。生物製剤とバイオシミラーセグメントは、2022年に北米のバイオプロダクション市場で最大のシェアを占めました。
アプリケーションの観点から、北米のバイオプロダクション市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他に分類されています。がんセグメントは、2022年に北米のバイオプロダクション市場で最大のシェアを占めました。
機器別に、北米のバイオプロダクション市場は、上流機器、下流機器、バイオリアクター、消耗品とアクセサリに分かれています。消耗品および付属品セグメントは、2022年に北米のバイオ生産市場で最大のシェアを占めました。
エンドユーザーの観点から見ると、北米のバイオ生産市場は、バイオ医薬品会社、契約製造組織、その他に分類されます。バイオ医薬品会社セグメントは、2022年に北米のバイオ生産市場で最大のシェアを占めました。
国別に見ると、北米のバイオ生産市場は、米国、カナダ、メキシコに分割されています。2022年には、米国が北米のバイオ生産市場シェアを独占しました。
Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Lonza Group AG、Merck KGaA、Sartorius AG、Thermo Fisher Scientific Inc.は、北米のバイオ生産市場で事業を展開している大手企業の一部です。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - North America Market Analysis
5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
6. North America Bioproduction Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Bioproduction Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Bioproduction Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Bioproduction Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Bioproduction Market – Revenue and Forecast to 2030 – Country Analysis
10.1 North America: Bioproduction Market
10.1.1 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1 Overview
10.1.1.2 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3 US: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.4 US: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.5 US: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.6 US: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11. Bioproduction Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Bio-Rad Laboratories Inc
2. Danaher Corp
3. F. Hoffmann-La Roche Ltd
4. Lonza Group AG
5. Merck KGaA
6. Sartorius AG
7. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.